Altimmune, Inc.·4

Oct 16, 7:00 PM ET

SAYARE MITCHEL 4

4 · Altimmune, Inc. · Filed Oct 16, 2020

Insider Transaction Report

Form 4
Period: 2020-09-24
Transactions
  • Exercise/Conversion

    Restricted Stock Units ("RSUs")

    2020-09-2425,2750 total
    Common Stock (25,275 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2020-09-24+25,27526,363 total
Footnotes (2)
  • [F1]Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
  • [F2]On June 25, 2020, the reporting person was granted 25,275 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION